Insulinic

What Insulinic does

Insulinic, doing business as Insulinic-Health Solutions, is a privately held direct-to-consumer medical practice headquartered at 220 Johnston Street in Lafayette, Louisiana. The practice focuses on the reversal of insulin resistance as the upstream cause of metabolic failure, treating patients with Type 2 diabetes and related complications such as neuropathy, weight gain, chronic fatigue, slow wound healing, memory loss, and kidney dysfunction. Services are delivered through a four-person multidisciplinary clinical team led by founder and CEO Shawn Calvit, comprising an Internal Medicine physician (Dr. Dale Leleaux), a Nurse Practitioner (Christy Lee), and a Dietitian/Nutritionist (Justin Hebert). Patients can self-book via the company's website or walk in without a referral, and the practice works with all insurance payers.

The clinical model combines a proprietary IV-infused medication protocol, described as a cellular "master key" intended to restore insulin sensitivity and downstream tissue repair, with a hardware diagnostic suite. The diagnostic stack centers on the TM Flow System, an integrated platform that combines ankle-brachial index measurement (peripheral artery disease screening), galvanic skin response/sudomotor function testing (SweatC Model A001 for small fiber neuropathy), and photoplethysmography spectral analysis (OXI_W Model D009 for autonomic and endothelial function). A standalone TBL-ABI Model C001 supports rapid vascular assessment. The PTG Spectral Analysis method used in the OXI_W device is patented, with peer-validated accuracy claims of 95.7% sensitivity for insulin resistance detection against the hyperinsulinemic euglycemic clamp and 86.1% sensitivity for endothelial function against coronary angiography.

Commercial operations are entirely concentrated at the single Lafayette clinic, which constrains revenue to whatever a four-person team can deliver through insured office visits and IV infusion series. Marketing runs through the insulinic.com website, which publishes condition-specific educational content to drive top-of-funnel patient acquisition. No funding rounds, parent company, institutional investors, partnerships, M&A activity, or external distribution arrangements are disclosed; ownership is founder-led, and the practice currently serves only the Louisiana market with no reported expansion, hiring momentum, or revenue figures.

Name

Insulinic

Legal name

Insulinic-Health Solutions

Website

https://insulinic.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Insulinic is a Lafayette, Louisiana medical practice that treats insulin resistance and metabolic dysfunction directly via proprietary IV-infusion protocols, supported by an in-clinic diagnostic stack (TM Flow, OXI_W, TBL-ABI, SweatC) for self-referred, insured patients.

Ownership category

akta.pro rank

Product category

Endocrinology / Diabetes Care Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Type 2 Diabetes Care (HLAKADAC)

akta.pro secondary industries

Diabetes (General) (HLAKADAA), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)

Keywords

• Insulin resistance treatment
• Diabetes management services
• Metabolic disorder reversal
• Vascular diagnostic testing
• IV infusion therapy

Headquarters

HQ city

Lafayette

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Treatment Services: Revenue generated from insulin resistance reversal treatment services including IV infused medications. The practice accepts insurance and works with all insurance payers to maximize patient benefits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Insulinic is a direct-to-consumer medical practice that provides insulin resistance reversal treatment through a proprietary IV-infused medication formula combined with in-house metabolic and vascular diagnostic testing. Services are delivered at a single Lafayette, Louisiana office and supported by four diagnostic devices (TM Flow System, TBL-ABI Model C001, OXI_W Model D009, and SweatC Model A001) for assessing autonomic nervous system, endothelial, sudomotor, and peripheral vascular function. Patients can book consultations online or walk in without a referral, and the practice bills all insurance payers.

Product overview

Insulinic is a healthcare practice offering insulin resistance reversal treatment and diagnostic services. The product portfolio centers on the TM Flow System as a unified diagnostic platform that integrates multiple measurement technologies, supplemented by standalone diagnostic devices (TBL-ABI Model C001, OXI_W Model D009, and SweatC Model A001) for assessing vascular function, autonomic nervous system activity, and sudomotor function. The core therapeutic offering is an IV-infused insulin resistance reversal treatment protocol.

Differentiator

Problem solved

Functional benefit

Products and services

• Insulin Resistance Reversal Treatment IV-infused medication protocol for patients with insulin resistance and metabolic disorders, designed to facilitate glucose absorption into cells, convert it to energy, and promote tissue repair and regeneration to reverse complications of diabetes and metabolic disorders.
• TM Flow System diagnostic service Comprehensive in-house diagnostic service combining ankle-brachial index measurement, galvanic skin response/sudomotor function testing, and photoplethysmography analysis for assessing autonomic nervous system, endothelial function, and peripheral arterial disease.
• TBL-ABI Model C001 diagnostic service In-house diagnostic service for rapid measurement of ankle-brachial pressure index (ABPI/ABI) and pulse volume recording (PVR) used for peripheral arterial disease screening, wound care assessment, and cardiovascular risk evaluation.
• OXI_W Model D009 diagnostic service In-house pulse oximetry and photoplethysmography (PTG) analysis service for assessing peripheral circulation, heart rate variability, and autonomic nervous system function through Ewing Tests.
• SweatC Model A001 diagnostic service In-house galvanic skin response service using sympathetic skin response methodology via foot skin disposable electrodes to assess sudomotor function and detect peripheral small fiber neuropathy.

Quantifiable outcome

• Reported improved neuropathy
• +4 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Livongo (Teladoc Health): Livongo, now part of Teladoc, pioneered connected devices and coaching for diabetes management at scale with major payer/employer contracts. Comparable diabetes-focused chronic care platform, but embedded inside a much larger telehealth incumbent.
• Noom Health: Noom is an established behavior-change platform with dedicated diabetes and weight-loss programs offered via employer and payer channels. Comparable reach to the same metabolic patient segment via a digital care model.
• Hims & Hers Health: Hims & Hers is a large DTC telehealth platform that now offers weight-loss and metabolic care (incl. GLP-1 prescriptions). Comparable as a scaled DTC clinical consumer brand expanding into metabolic care.

Direct peers

• Virta Health: Virta Health is a DTC telehealth medical practice that reverses Type 2 diabetes via nutrition and remote monitoring, accepting employer/payer contracts. Directly comparable to Insulinic's positioning as a clinical provider reversing insulin resistance / Type 2 diabetes rather than just managing it.
• Omada Health: Omada Health runs virtual cardiometabolic care programs (diabetes prevention, diabetes management, hypertension) sold through payers and employers. Comparable as a digital-first chronic metabolic care provider targeting the same insulin-resistant / pre-diabetic population.
• Found (Found Health): Found is a DTC telehealth practice combining physician-led care with prescriptions (incl. GLP-1s) and behavior change for weight and metabolic health. Comparable to Insulinic as a DTC medical practice treating metabolic dysfunction directly with patients paying out-of-pocket or via insurance.
• Forward Health: Forward is a membership-based DPC practice using advanced diagnostics and personalized care plans for chronic conditions including metabolic health. Comparable clinical model (DPC + diagnostics-driven care) and overlap on cardiometabolic focus.

Emerging players

• Click Therapeutics: Click Therapeutics develops prescription digital therapeutics, including programs for diabetes management. Adjacent comparable on the digital-therapeutic approach to diabetes care, though product-form (software DTx) differs from Insulinic's IV-based clinical practice.
• Levels Health: Levels is a consumer metabolic-health platform built around CGM data and behavior coaching. Partial overlap on the insulin-resistance/metabolic-health audience; differs by being an app/data layer rather than a treating clinic.
• mySugr (Roche): mySugr is a diabetes self-management app with bolus calculator, logging, and Roche device integration. Compares on the dose-decision / diabetes digital therapeutic angle that overlaps with Insulinic's PTG-based decision support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

• Xx.com/insulinic
• Facebookfacebook.com/insulinic
• LinkedInlinkedin.com/company/insulinic

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Insulinic